EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Earth Science Tech Inc (ETST) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Earth Science Tech Inc $0.20, price $0.09, upside +120.0%, quality 74 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN US2703111037

ES Earth Science Tech Inc logo Thin data Sep 23, 2026

Earth Science Tech Inc

ETST · US

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value $0.1980 · Strongly undervalued (+120%)
✓Quality 74/100
!Mixed Growth (revenue 5y +129.0 %/yr)
✓Solidly profitable · 10.1% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (11/13)
✓Wide moat 69/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.3199 $0.0103 Fair Value $0.1980 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.0103 – $0.3199 · fair‑value band $0.1440 – $0.2970 · the $0.0900 price screens below the $0.1980 fair value. Dashed = 300-day average. As of Sep 23, 2026.

Follow Earth Science Tech in your weekly email

Every Wednesday you see whether Earth Science Tech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in compounding pharmaceuticals, telemedicine, and real estate development activities.

Show more

Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in compounding pharmaceuticals, telemedicine, and real estate development activities. The company also operates Peaks, a telemedicine referral platform focused on health and wellness for men and women; and pharmacies under the RxCompound and Mister Meds name. In addition, it is involved in the development and management of real estate assets. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.

Stock analysis

Earth Science Tech Inc (ETST) currently trades at $0.0900, while our model-based Fair Value estimate is $0.1980, implying the stock looks roughly 54.5% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $0.5200 per share, and 21 of the 24 models we run sit above the $0.0900 price.

Bear case: the Economic Profit group reads lowest at $0.1000, and 3 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.1440 (bear) to $0.2970 (bull), the price of $0.0900 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 74/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Earth Science Tech Inc reported revenue of $33.1M in FY2025 versus $141K in FY2021, a compound +291.5%/yr. Reported net income was $3.3M in FY2025.

Key figures

Market cap $51.3M · P/E ratio 9.0 · P/S ratio 0.88 · EPS (TTM) $0.0100 · Net margin 9.8% · Return on equity 76.8% · Return on assets (EBIT) −176% · Operating margin 19.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 62% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at 120%, ETST screens cheaper than that median.

Fair Value models

Bear $0.1440 Fair Value $0.1980 Bull $0.2970
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($0.0100 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $0.1900 $0.2700 $0.4900 75
Growth DCF $0.1800 $0.2900 $0.4600 75
EPV $0.0800 $0.0900 $0.1000 74
All 24 models by family
DCF Models
FCF DCF $0.1900 $0.2700 $0.4900 75
Owner Earnings $0.1400 $0.2800 $0.5100 70
5Y Revenue Exit $0.1500 $0.2300 $0.4100 68
5Y EBITDA Exit $0.1600 $0.2500 $0.4400 70
5Y P/E Exit $0.1900 $0.4000 $0.6800 66
10Y Revenue Exit $0.1600 $0.3000 $0.3800 65
10Y EBITDA Exit $0.1700 $0.3200 $0.5700 63
10Y P/E Exit $0.1900 $0.3800 $0.7000 59
Earnings-Based
Graham-Dodd $0.0800 $0.5300 $0.7400 61
Lynch FV $0.2700 $0.3900 $0.5100 59
PEG = 1.0 $0.2700 $0.3900 $0.5100 55
EPV $0.0800 $0.0900 $0.1000 74
Multiples
P/E Multiple $0.1800 $0.2500 $0.3100 63
P/S Multiple $0.1400 $0.1900 $0.2400 58
P/B Multiple $0.0400 $0.0600 $0.0700 55
EV/EBIT $0.1600 $0.2100 $0.2600 66
EV/EBITDA $0.1300 $0.1800 $0.2200 67
EV/Revenue $0.1100 $0.1600 $0.2000 54
Asset-Based
NCAV (Graham) $0.0100 $0.0100 $0.0100 55
Growth DCF
Growth DCF $0.1800 $0.2900 $0.4600 75
Rev-Margin DCF $0.1600 $0.2700 $0.4900 67
Economic Profit
Residual Income $0.0600 $0.1000 $1.87 56
ROIC Compounder $0.0900 $0.1100 $0.1300 70
Growth Earnings
Growth-Adj P/E $0.3600 $0.5200 $0.6700 65

Open the full fair value analysis →

Notify me when ETST reaches fair value

Put ETST on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 74/100

Of which business quality 74 · Market factors (momentum, volatility) 4

Profitability 89
Margins and returns on capital today
Quality Growth 94
Are margins and returns improving?
Cashflow 60
Earnings quality: real cash, not paper profit
Fin. Strength 90
Balance sheet, leverage, solvency risk
Investment 49
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 8
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 50
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 92/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+177.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+129.0%
Start year 2020 (pandemic). Over 10 years: +82.6% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+75.3%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
−41.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−41.3%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−157% → 10%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −2.2% a year for the price.

Watch ETST, get fair value alerts →

Compare Earth Science Tech Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 629 stocks

Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 74 · Top 25%
Fair Value upside +116% · Top 25%
Profitability
Return on equity (TTM) 77% · Top 25%
Return on assets 41% · Top 25%
Net margin (TTM) 10% · Above median
Operating margin (TTM) 19% · Top 25%
Growth and dividend
Revenue growth 14% · Above median
Balance sheet
Debt / equity 0.01× · Lowest 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/E (TTM) 9.0× · Cheapest 25%
P/B 13.32× · Priciest 25%
P/S (TTM) 1.47× · Cheaper than median
P/FCF 14.2× · Priciest 25%
EV/EBITDA 10.4× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 15
FUTURE (revenue growth)71 · sector 20
PAST (return on equity)100 · sector 27
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €133.95 €108.70 −19%
Takeda Pharmaceutical Company TAK $18.81 $11.29 −40%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥45.58 ¥50.14 +10%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,865 ₹1,979 +6%
Galderma Group GALD CHF 163.80 CHF 109.88 −33%
Haleon plc HLN $9.25 $8.50 −8%
Teva Pharmaceutical Industries Limited TEVA $39.01 $20.75 −47%
Sandoz Group SDZ CHF 70.76 CHF 40.16 −43%
Zoetis Inc ZTS $71.61 $108.48 +51%
Hansoh Pharmaceutical Group 3692 HK$35.34 HK$38.87 +10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Earth Science Tech Inc Fair Value". https://www.fairvalue-calculator.com/stock/ETST

Frequently asked questions

Is Earth Science Tech Inc (ETST) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.1980 versus a price of $0.0900, about +120% upside (undervalued).
What is the fair value of ETST?
Our model-based fair value for Earth Science Tech Inc is $0.1980 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.0900.
What is the quality score of ETST?
Earth Science Tech Inc has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Earth Science Tech Inc (ETST)?
Our model-based price target is the fair value of $0.1980 (as of Sep 23, 2026) from 24 valuation models. Cautious scenario $0.1440, optimistic scenario $0.2970. It is a calculation from audited fundamentals, not an analyst target.
What is the Earth Science Tech Inc stock forecast for 2026?
Our models put fair value at $0.1980, about +120% upside versus a price of $0.0900 (undervalued). Cautious scenario $0.1440, optimistic scenario $0.2970. The calculation is refreshed regularly with new filings.
What is the revenue of Earth Science Tech Inc (ETST)?
Earth Science Tech Inc reported trailing-twelve-month revenue of about $34.9M (latest available figure, as of Sep 23, 2026).
What growth is priced into Earth Science Tech Inc (ETST)?
For today's price to be fair in a discounted-cash-flow model, Earth Science Tech Inc would have to grow free cash flow by +0.1 % per year for five years (discount rate 15.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +129.0 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of ETST use?
Our models discount Earth Science Tech Inc at 15.2 %: a base by market capitalisation (micro), damped by beta 2.40, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Earth Science Tech Inc that is +0.1 % per year a year over ten years, using the same discount rate (15.2 %) and the same formula as our fair value.
How much growth has Earth Science Tech Inc (ETST) delivered so far?
Over the past 5 years revenue at Earth Science Tech Inc grew +129.0 % a year. The price currently implies +0.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Earth Science Tech Inc (ETST) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Earth Science Tech Inc (+0.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Earth Science Tech Inc (ETST)?
The free-cash-flow yield on the price is 13.25 %: that much free cash flow Earth Science Tech Inc produces per unit of market value. When it exceeds the discount rate of our models (15.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Earth Science Tech Inc (ETST)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Earth Science Tech Inc it is $0.1980 per share (as of Sep 23, 2026), against a price of $0.0900. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Earth Science Tech Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, ETST trades below its calculated fair value: price $0.0900, fair value $0.1980, a gap of about +120% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ETST?
No. The price is what the market pays today ($0.0900); the fair value is what the company's own numbers justify ($0.1980). For Earth Science Tech Inc the two are $0.1080 per share apart. That gap is exactly why we show both numbers side by side.
How much is Earth Science Tech Inc worth?
The market values Earth Science Tech Inc at about $51.3M (market capitalisation, as of Sep 23, 2026). Per share that is $0.0900; our models calculate a fair value of $0.1980 per share.
What do the bullish and bearish scenarios say about ETST?
Our models span a range for Earth Science Tech Inc: cautious scenario $0.1440, base $0.1980, optimistic $0.2970 per share (as of Sep 23, 2026, price $0.0900). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ETST?
Earth Science Tech Inc trades at a price-to-earnings ratio of 9.0 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.1980 is built from several models across several years. Other multiples: P/B 13.3, P/S 1.5, EV/EBITDA 10.4.
How solid is the balance sheet of Earth Science Tech Inc (ETST)?
Balance-sheet figures for Earth Science Tech Inc (as of Sep 23, 2026): return on equity 76.8%, debt of 0.01 per unit of equity. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is ETST from its 52-week high?
Earth Science Tech Inc trades at $0.0900, about 62% below its 52-week high of $0.2370 and 8% above the low of $0.0831 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $0.1980 is for.
Which stocks are comparable to Earth Science Tech Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Earth Science Tech Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $0.0900, calculated fair value $0.1980 (+120%), Quality Score 74/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ETST calculated?
We run Earth Science Tech Inc through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.1980, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Earth Science Tech Inc currently trades 120 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Earth Science Tech Inc (ETST)?
The closing price on Sep 24, 2026 was $0.0900. Our model-based fair value is $0.1980, about +120% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Earth Science Tech Inc right now?
The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case ($0.1440). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.1440 to $0.2970) leaves room in how you read the outcome.

Key figures of Earth Science Tech Inc

How large is the market capitalisation of Earth Science Tech Inc (ETST)?
The market capitalisation of Earth Science Tech Inc is $51.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Earth Science Tech Inc (ETST)?
The price-to-sales ratio of Earth Science Tech Inc is 0.88 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Earth Science Tech Inc (ETST)?
Earnings per share at Earth Science Tech Inc are $0.0100 (price ÷ EPS = P/E 9.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Earth Science Tech Inc (ETST)?
The net margin of Earth Science Tech Inc is 9.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Earth Science Tech Inc (ETST)?
The return on equity (ROE) of Earth Science Tech Inc is 76.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Earth Science Tech Inc (ETST)?
On an EBIT basis the return on assets of Earth Science Tech Inc is −176% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Earth Science Tech Inc (ETST)?
The operating margin of Earth Science Tech Inc is 19.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Earth Science Tech Inc (ETST)?
Revenue at Earth Science Tech Inc is growing +14.1% versus a year earlier (3y avg +1,229%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Earth Science Tech Inc (ETST)?
Earnings per share at Earth Science Tech Inc are growing +357% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Earth Science Tech Inc (ETST) hold?
Earth Science Tech Inc holds more cash than debt, $1.1M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Earth Science Tech Inc in the live analysis

One click puts Earth Science Tech Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.